Surgeons weigh the merits of a new characterization of pre-cataract.
This technology promises to improve many patients’ vision, but surgeons need to start slowly.
One approved, two in trials, the inlays offer differing mechanisms of action.
To subscribe to our optical e-newsletters and receive them via e-mail, click here.
Copyright© 2000 - 2016 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.